Healthcare

The advent of DNA sequencing has revolutionized our understanding of biology, bringing an unparalleled level of insight into genetics. DNA sequencing also offers the potential for highly personalized healthcare: by incorporating a patient's genomic information into their health records, treatments may potentially be tailored towards individual patients. The IDTechEx report, "DNA Sequencing 2023-2033: Technologies, Markets, and Forecasts" explores the technologies and markets of the US$8.2 billion DNA sequencing industry.

The most comprehensive assessment on the commercialization of flexible, wearable electronic skin patches spanning 13 applications including historic data, 10-year market forecast, interview-based player profiles, and technology analysis.

Could gas sensors facilitate the safe use of wood-burning stoves to combat the energy crisis? With the cost of energy rising dramatically, interest in wood-burning stoves is growing as they become 'more financially appealing than ever'.

IDTechEx Reflects on Trends in 2022. For the past decade, the healthcare industry has looked towards decentralization as a means of relieving the pressure placed on healthcare systems.

Thursday 3 November 2022 - This webinar will break down the complex landscape of sensor types, biometrics, and form factors; highlight innovations in electrode integration; discuss optical sensing advancements; and overview opportunities and challenges for microneedles as wearable sensors

The latest wearable sensors report from IDTechEx, "Wearable Sensors 2023-2033", breaks down the complex landscape of sensor types, biometrics, and form factors. IDTechEx highlights the key opportunities and challenges for each sensor type to achieve commercial success across the next ten years.

Wednesday 12 October 2022 - IDTechEx forecasts the DNA sequencing market to exceed US$12 billion by 2033. This webinar will explore the growing DNA sequencing industry and evaluate the potential future of the market.

Remote patient monitoring (RPM), referring to the use of technology to measure and transmit physiologic data beyond traditional healthcare settings, has emerged as a promising solution to drive down healthcare costs while maintaining a high standard of care for patients.

Since its inception, DNA sequencing has brought about major advancements in our understanding of biology. The breadth of information this technology can offer has the potential to revolutionize healthcare, drug discovery, and many other fields.

In recent times, we have all experienced the value of diagnostics used in the comfort and ease of our own homes. Imagine if we could look for other infectious diseases just as easily, with less invasive, self-administered, highly accurate, and reliable tests. With the convergence of advances in telehealth and biotechnology, this is the direction that the diagnostics industry is heading towards.